ArticleLeukemia2008

BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells.

P Pérez-Galán et al.PubMed ↗Publisher ↗

No numbers read from the abstract.